What We Support
Cookies for Kids' Cancer has a specific mission to support the development of safer, more effective treatments for pediatric cancers; bringing promising new developments to clinic as quickly as possible to help children TODAY.
The Facts About Childhood Cancers:
Where the Funds Go:
- 1 in 300 children will be diagnosed with cancer by the time they're 20 years old.
- There are 12 major types of pediatric cancer, each as unique as the child fighting it.
- Less than 4% of the National Cancer Institute's budget goes towards pediatric cancers.
- 2/3 of survivors develop long-term effects, including secondary cancers, a result of treatments that first cured them.
This year, we are proud to announce grants totaling $1.5 million, bringing our total amount granted to $5 million in just a few short years. Click here to view the 2013 grants and learn more about what your funds support.
Our Medical Advisory Board
Funding is overseen by a Medical Advisory Board, consisting of some of the nation's leading pediatric oncology professionals. The Board helps us identify the most critical needs and promising developments.
Your donations can be directed to a specific cancer or fund. If you donate to our General Fund, the Board will guide fund granting through a peer review process.
Statement of Need
The field of pediatric oncology has come a long was in the last several decades. Cure rates have improved dramatically and advances in childhood cancer research has provided seminal insights into the cancer problem in general.
The major problem is that this cure rate has come at significant cost. First, the intensity of chemotherapy and radiation therapy used to achieve this cure rate has increased substantially, so that the majority of survivors have significant long-term complications of therapy.
Clearly, cure is not enough. Of equal urgency, several cancers, especially the solid malignancies, have not shown improvement in cure rates and current treatments are at their maximal intensity. Indeed, several cancers have seen no significant progress in over a decade and childhood cancer remains the number one cause of death in children from disease (accidents claim the most lives).
Cancer research is essential to achieving the goal of cure with quality for all children with cancer. Cancer research is responsible for the achievements to date, with pediatric oncologist showing the world how to perform meaningful clinical research that influences clinical care. However, the next generation of research that will lead to meaningful differences is quite different, and will rely on a detailed understanding of cancer biology with a newly facile was to translate discoveries to the clinic. It is often said that it takes a decade to develop a new cancer drug.
Clearly, this timeline is not acceptable. We have recently dramatically decreased the time line to get new targeted therapies to children with refractory cancer, and this new translational molecular oncology will be the pathway to the next revolution in cure rates. However, this type of research with demanding deadlines and urgent translation to patients is resource intensive.
Philanthropic investment in key pediatric cancer research programs will provide the essential catalyst to make more discoveries and move them to improving cure rates as quickly as possible, and a partnership between researchers and “investors” in this mission will be critical to expand in order to make a difference now.
John M. Maris, M.D., Children's Hospital of Philadelphia
Follow us on Facebook and Twitter, and sign up for our E-newsletterfor exclusive updates!